References
- Gavrielov-YusimNFrigerMUse of administrative medical databases in population-based researchJ Epidemiol Community Health201468328328724248997
- IezzoniLIAssessing quality using administrative dataAnn Intern Med19971278 Pt 26666749382378
- CDC/NHSNumber and rate of discharges from short-stay hospitals and of days of care, with average length of stay and standard error, by selected first-listed diagnostic categories: United States, 2010CDC/NCHS National Hospital Discharge Survey2010 Available from: http://www.cdc.gov/nchs/data/nhds/2average/2010ave2_firstlist.pdfAccessed June 22, 2015
- Centers for Disease Control and PreventionMurphySLXuJKochanekKDDeaths: Final Data for 2010 National Vital Statistics Reports2013614 Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdfAccessed June 13, 2015
- RestrepoMIMortensenEMPughJAAnzuetoACOPD is associated with increased mortality in patients with community-acquired pneumoniaEur Respir J200628234635116611653
- SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
- MullerovaHChigboCHaganGWThe natural history of community-acquired pneumonia in COPD patients: a population database analysisRespir Med201210681124113322621820
- RyanMSuayaJAChapmanJDStasonWBShepardDSThomasCPIncidence and cost of pneumonia in older adults with COPD in the United StatesPLoS One2013810e7588724130749
- BratzlerDWNormandSLWangYAn administrative claims model for profiling hospital 30-day mortality rates for pneumonia patientsPLoS One201164e1740121532758
- BrouletteJYuHPyensonBIwasakiKSatoRThe Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age PopulationAm Health Drug Benefits20136849450324991378
- DavydowDSHoughCLZivinKLangaKMKatonWJDepression and risk of hospitalization for pneumonia in a cohort study of older AmericansJ Psychosom Res201477652853425139125
- JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
- LinJLiYTianHCosts and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumoniaClinicoecon Outcomes Res2014634935625075195
- LindenauerPKNormandSLDryeEEDevelopment, validation, and results of a measure of 30-day readmission following hospitalization for pneumoniaJ Hosp Med20116314215021387551
- ThomasCPRyanMChapmanJDIncidence and Cost of Pneumonia in Medicare BeneficiariesChest2012142497398122406959
- PolskyDBonafedeMSuayaJAComorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adultsBMC Health Serv Res20121237923113880
- ReynoldsCAFinkelsteinJARayGTMooreMRHuangSSAttributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysisAntimicrob Resist Infect Control201431624851182
- RuhnkeGWCoca-PerraillonMKitchBTCutlerDMMarked Improvement in 30-Day Mortality among Elderly Inpatients and Outpatients with Community-Acquired PneumoniaAm J Med20121422171178
- SatoRGomez ReyGNelsonSPinskyBCommunity-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 yearsAppl Health Econ Health Policy201311325125823605251
- Thornton-SniderJLunaYWongKSInhaled corticosteroids and the risk of pneumonia in Medicare patients with COPDCurr Med Res Opin201228121959196723098081
- TichopadARobertsCGembulaIClinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and SlovakiaPLoS One201388e7137523940743
- YawnBPLiYTianHZhangJArconaSKahlerKHInhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysisInt J Chronic Obstruct Pulmon Dis20138295304
- AstraZenecaComparative Effectiveness of Symbicort vs Advair Among COPD Patients Available from: http://clinicaltrials.gov/show/NCT1921127. NLM identifier: NCT1921127Accessed June 13, 2015
- KernDMDavisJWilliamsSAComparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database studyRespir Res20151615225899176
- AronskyDHaugPJLagorCDeanNCAccuracy of administrative data for identifying patients with pneumoniaAm J Med Qual200520631932816280395
- WhittleJFIneMJJoyceDZCommunity-acquired pneumonia: can it be defined with claims data?Am J Med Qual19971241871939385729
- SkullSAAndrewsRMByrnesGBICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or =65 yearsEpidemiol Infect2008136223224017445319
- WilliamsDJShahSSMyersAIdentifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codesJAMA Pediatr2013167985185823896966
- YuONelsonJCBoundsLJacksonLAClassification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative dataEpidemiol Infect201113991296130621087538
- FileTMCommunity-acquired pneumoniaLancet200336294001991200114683661
- NuortiJPButlerJCFarleyMMCigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance TeamN Engl J Med20003421068168910706897
- MandellLAWunderinkRGAnzuetoAInfectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClin Infect Dis200744Suppl 2S27S7217278083
- DrahosJVanwormerJJGreenleeRTLandgrenOKoshiolJAccuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative dataAnn Epidemiol201323529129323522903